We are delighted to announce that, thanks to our loyal customers, the Cellaca™ MX High-throughput Cell Counter has been nominated in the Life Sciences category.
Available on demand. In this informational webinar, Dr. Dmitry Kuksin, Nexcelom Senior Scientist, examines specific virology related assays such as plaque and foci formation, as well as antibody neutralization.
Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.
Nexcelom's China team works with scientists in State Key Laboratory of Respiratory Diseases in China, for the screening of antiviral agents against SARS-CoV-2 virus, the cause of COVID-19 (Corona Virus).
Available on demand. During this webinar, Dr. Thomas will share his research in cancer biology related to DNA damage in the onset of solid tumors.
Immunotherapy is a diverse and broad catch-all for any treatments and therapies that utilize the patient’s own immune response to mount a defense.
In this webinar, we highlight a variety of assays to support the development of cell therapies for solid tumors.
Improved fluorescent plaque assay method using fluorescently-labeled antibodies and the use of the Celigo image cytometer.
In this webinar we highlight the differences between trypan blue and fluorescence-based cell counting methods.
Improve Seahorse XF results using direct cell counting. An important step in performing SeahorseTM XF cell metabolism analysis is normalization of the resultant data.
